Tesofensine
Typical Dosage
0.25 mg - 1 mg
Administration
Oral
Half-Life
Long; often cited around 9 days for active moieties
Mechanism of Action
Obesity pharmacology|Monoamine reuptake inhibition|Appetite suppression studies|Weight-loss trials
Research Protocol Summary
Evidence Level
Early Human / Investigational
Typical Protocol Duration
12 Weeks
Species Studied
Human • Rat
Administration Schedule
Daily
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…